BOOST cells(Karolinska Institutet)(BOOST cells(Karolinska Institutet)) - 在研适应症：成骨不全_专利_临床

概要

基本信息

药物类型

细胞疗法

别名-

靶点-

作用方式-

作用机制-

治疗领域

遗传病与畸形皮肤和肌肉骨骼疾病其他疾病

在研适应症

成骨不全

非在研适应症-

原研机构

Karolinska Institutet

在研机构

Karolinska Institutet

非在研机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 BOOST cells(Karolinska Institutet) 相关的临床试验

NCT03706482

/ Active, not recruiting临床1/2期IIT

An Exploratory, Open Label, Multiple Dose, Multicentre Phase I/II Trial Evaluating Safety and Efficacy of Postnatal or Prenatal and Postnatal Intravenous Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta Compared With a Combination of Historical and Untreated Prospective Controls

An exploratory, open label, multiple dose, multicentre phase I/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe Osteogenesis Imperfecta compared with a combination of historical and untreated prospective controls.

开始日期2019-08-12

申办/合作机构

Karolinska Institutet

[+7]

NCT04623606

/ Unknown status临床1/2期IIT

Exploratory, Open Label, Multiple Dose, Phase I/II Trial Evaluating Safety, Efficacy of Intravenous and Intraosseous Infusion of Allogeneic Fetal Mesenchymal Stem In Treatment of Severe Osteogenesis Imperfecta Compared With Historical and Untreated Prospective Controls

An exploratory, open label, multiple dose, phase I/II trial (n=15) evaluating safety and efficacy of intravenous and intraosseous infusion of allogeneic expanded fetal mesenchymal stem cells (MSC) for the treatment of severe Osteogenesis Imperfecta (OI) compared with historical and untreated prospective controls.

开始日期2019-05-20

申办/合作机构